Analysts Anticipate HCA Healthcare Inc (HCA) Will Announce Earnings of $2.58 Per Share

Brokerages expect HCA Healthcare Inc (NYSE:HCA) to announce earnings per share of $2.58 for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have provided estimates for HCA Healthcare’s earnings. The highest EPS estimate is $2.68 and the lowest is $2.46. HCA Healthcare reported earnings of $2.12 per share in the same quarter last year, which would suggest a positive year over year growth rate of 21.7%. The firm is scheduled to report its next quarterly earnings results on Tuesday, January 29th.

On average, analysts expect that HCA Healthcare will report full year earnings of $9.35 per share for the current year, with EPS estimates ranging from $9.23 to $9.45. For the next financial year, analysts anticipate that the business will post earnings of $10.12 per share, with EPS estimates ranging from $9.39 to $10.50. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that cover HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.13 earnings per share.

HCA has been the subject of several analyst reports. Morgan Stanley increased their target price on shares of HCA Healthcare from $91.00 to $98.00 and gave the company an “underweight” rating in a report on Friday, July 13th. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 target price for the company in a report on Monday, July 16th. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. SunTrust Banks reiterated a “buy” rating and issued a $125.00 target price on shares of HCA Healthcare in a report on Friday, July 20th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $115.00 target price on shares of HCA Healthcare in a report on Friday, July 20th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $141.53.

Shares of HCA stock opened at $143.95 on Friday. The stock has a market capitalization of $48.75 billion, a PE ratio of 21.84, a PEG ratio of 1.24 and a beta of 0.48. HCA Healthcare has a one year low of $74.26 and a one year high of $144.18.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 0.97%. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

In related news, insider Michael S. Cuffe sold 4,943 shares of the firm’s stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $141.90, for a total transaction of $701,411.70. Following the completion of the sale, the insider now owns 33,240 shares in the company, valued at $4,716,756. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jane D. Englebright sold 6,543 shares of the firm’s stock in a transaction dated Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The disclosure for this sale can be found here. Insiders have sold 22,486 shares of company stock valued at $3,079,086 in the last 90 days. 2.80% of the stock is currently owned by corporate insiders.

A number of large investors have recently modified their holdings of HCA. State of Alaska Department of Revenue boosted its position in HCA Healthcare by 27.7% during the second quarter. State of Alaska Department of Revenue now owns 45,700 shares of the company’s stock worth $4,687,000 after purchasing an additional 9,910 shares during the period. Confluence Investment Management LLC bought a new position in HCA Healthcare during the second quarter worth about $283,000. NN Investment Partners Holdings N.V. boosted its position in HCA Healthcare by 198.9% during the second quarter. NN Investment Partners Holdings N.V. now owns 170,204 shares of the company’s stock worth $17,463,000 after purchasing an additional 113,265 shares during the period. Campbell & CO Investment Adviser LLC bought a new position in HCA Healthcare during the second quarter worth about $259,000. Finally, Bank of Montreal Can boosted its position in HCA Healthcare by 49.5% during the second quarter. Bank of Montreal Can now owns 506,077 shares of the company’s stock worth $51,922,000 after purchasing an additional 167,599 shares during the period. Hedge funds and other institutional investors own 70.84% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Float

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply